BioCentury
ARTICLE | Company News

Management tracks

April 7, 2015 12:22 AM UTC

Protein therapeutics company Acceleron Pharma Inc. (NASDAQ:XLRN) named Francois Nader chairman. Nader joined the company's board in December. He was CEO and director of NPS Pharmaceuticals Inc., which was acquired by Shire plc (LSE:SHP; NASDAQ:SHPG). ...